Literature DB >> 1192691

A common mechanism for transport of di- and tri-peptides by hamster jejunum in vitro.

J M Addison, D Burston, J A Dalrymple, D M Matthews, J W Payne, M H Sleisenger, S Wilkinson.   

Abstract

1. This paper describes the results of a survey of the effects of peptides and amino acids on uptake by rings of everted hamster jejunum in vitro of glycylsarcosylsarcosine, a tripeptide which is taken up by an active mechanism but is very resistant to hydrolysis, appearing intact in the rings. The results of a small number of similar experiments with beta-alanylglycylglycine, another tripeptide which is taken up with very little hydrolysis, are also described. 2. Uptake of the two tripeptides was inhibited by other di- and tri-peptides, but not by free amino acids. The results suggest that dipeptides and tripeptides share a common uptake mechanism. The tetrapeptide glycylsarcosylsarcosylsarcosine did not inhibit uptake of glycylsarcosylsarcosine, and appears to be unable to utilize the uptake mechanism. 3. The results add to information about the influence of molecular structure on intestinal uptake of peptides by the system used by glycylsarcosylsarcosine, which is shared by a wide range of other di- and tri-peptides. In conjunction with previous results, they suggest that substitution of the N-terminal amino or C-terminal carboxyl groups reduces affinity for transport, that the presence of a beta-amino acid residue in a peptide is tolerated by the transport system, and that the presence of a D-amino acid residue reduces affinity for transport. Some peptides containing or made up of basic or acidic amino acid residues appear to have a low affinity for the transport system used by glycylsarcosylsarcosine. 4. Of two biologically active peptides, one, cephalexin, a peptide antibiotic, inhibited uptake of glycylsarcosylsarcosine and is probably transported by the same system. The other, prolylleucylglycineamide, which has the action of a hypothalamic regulatory factor, did not, and its structural features may make it unsuitable for carrier-mediated transport by the small intestine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1192691     DOI: 10.1042/cs0490313

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  9 in total

Review 1.  Intestinal peptide transport systems and oral drug availability.

Authors:  C Y Yang; A H Dantzig; C Pidgeon
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.

Authors:  Diana Højmark Omkvist; Birger Brodin; Carsten Uhd Nielsen
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

3.  A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).

Authors:  Diana Højmark Omkvist; Simon Birksø Larsen; Carsten Uhd Nielsen; Bente Steffansen; Lars Olsen; Flemming Steen Jørgensen; Birger Brodin
Journal:  AAPS J       Date:  2010-05-08       Impact factor: 4.009

4.  Peptide transport by germinating barley embryos: Uptake of physiological di- and oligopeptides.

Authors:  C F Higgins; J W Payne
Journal:  Planta       Date:  1978-01       Impact factor: 4.116

5.  Characterisation of penicillin G uptake in human small intestinal brush border membrane vesicles.

Authors:  J F Poschet; S M Hammond; P D Fairclough
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 6.  Intestinal absorption of peptide drugs: advances in our understanding and clinical implications.

Authors:  S M Catnach; P D Fairclough; S M Hammond
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

7.  Relationships between mucosal hydrolysis and transport of two phenylalanine dipeptides.

Authors:  D B Silk; J A Nicholson; Y S Kim
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

Review 8.  Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery.

Authors:  J P Bai; G L Amidon
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

9.  Structural requirements for the intestinal mucosal-cell peptide transporter: the need for N-terminal alpha-amino group.

Authors:  P F Bai; P Subramanian; H I Mosberg; G L Amidon
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.